Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.
about
Metabolic syndrome, diabetes, and cardiovascular risk in HIVInsulin resistance change and antiretroviral therapy exposure in HIV-infected and uninfected Rwandan women: a longitudinal analysisAssociations of HIV infection with insulin and glucose levels in antiretroviral-naive Rwandan women: a cross-sectional analysis.HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyAntiretroviral therapy in the clinicA survey of the management, control, and complications of diabetes mellitus in patients attending a diabetes clinic in Blantyre, Malawi, an area of high HIV prevalenceDiabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus.Genital mycotic infections in patients with diabetes.Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines.Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women's Interagency HIV Study.Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.Cerebrovascular risk factors and brain microstructural abnormalities on diffusion tensor images in HIV-infected individualsAssociation of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetesThe association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study.Vitamin D and insulin resistance in non-diabetic women's interagency HIV study participants.High glucose enhances HIV entry into T cells through upregulation of CXCR4.Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.Women and HIV infection: the makings of a midlife crisisAntiretroviral Therapy-induced Insulin Resistance and Oxidative Deoxy Nucleic Acid Damage in Human Immunodeficiency Virus-1 PatientsRole of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.The challenge of diabetic foot care: Review of the literature and experience at Queen Elizabeth Central Hospital in Blantyre, Malawi.Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.Safety and effectiveness of U-500 insulin therapy in patients with insulin-resistant type 2 diabetes mellitus.Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50.
P2860
Q26853470-661DB7DE-120B-4562-9D5B-6BAFD4E6F2B5Q30389026-8A6696BA-02BD-491B-9E11-EE5D42E69697Q30392716-F84759D6-293B-4A5F-A158-9ED6C2B4A5F9Q33731258-D6B82AE6-CC22-467F-991D-4BDD66F08484Q33877347-2571EE09-5BB4-4091-9C38-8656EB32A604Q34087385-9C4166B1-D6D7-4F14-BAA5-826F05FA5EF8Q34157971-6CAF6BF5-19E7-414A-B5C7-41F9B6D22482Q34349532-BB047BB3-FD3D-44CE-9EC5-F62C180D3BF7Q34539440-36C83CF6-4AA2-4D0F-B1CF-E43E26D054B4Q35904492-FD96EE5C-AEF7-4129-A5E1-91F636BDF6FBQ36104762-171C4EA1-614B-4575-AFFB-08F624E99F56Q36169866-FEFD6DDF-CADD-4A42-B23C-257E83E4B28CQ36346682-E7F775E2-8772-4CCC-B413-F6E84BF53618Q36487277-61B83173-1C99-4634-ADF1-F6EAA8016FF1Q36899859-D03E4CA9-B180-4523-8B22-681E7F02BCC4Q37176327-97BFBC0E-1480-4713-A0B0-0241A6F8732FQ37305570-2938B677-ECEA-4CF5-85BC-440338062C70Q37442656-8FDBD8CE-C14E-4E10-8C68-2546A7FD9147Q37721953-7FD50DF4-34A0-4E78-8E0B-72EF064BCE6CQ38687132-1364C39A-6A61-42D0-BAB0-225A45BE1C28Q40374706-1423410B-77DA-4ABA-8212-3FD627189802Q41686328-809AD217-6DA4-4B49-8BE5-D39C1BEA7565Q42612040-4417469E-371A-417F-8F1D-2BD38B30D536Q42994549-5388F42F-3BDF-476A-9B61-8757567B7872Q44189369-276311AE-9503-45C0-911E-8063CB816D11Q44472782-9092D893-B740-460D-BBE8-A6FEE08E1C4AQ47118049-D8650AA8-A0AD-4882-B9F7-6F862A795B7B
P2860
Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antiretroviral therapy exposur ...... Women's Interagency HIV study.
@ast
Antiretroviral therapy exposur ...... Women's Interagency HIV study.
@en
type
label
Antiretroviral therapy exposur ...... Women's Interagency HIV study.
@ast
Antiretroviral therapy exposur ...... Women's Interagency HIV study.
@en
prefLabel
Antiretroviral therapy exposur ...... Women's Interagency HIV study.
@ast
Antiretroviral therapy exposur ...... Women's Interagency HIV study.
@en
P2093
P2860
P1476
Antiretroviral therapy exposur ...... Women's Interagency HIV study.
@en
P2093
Alexandra M Levine
Jack DeHovitz
Jessica E Justman
Mardge Cohen
Mary Young
Michael F E Schneider
Phyllis C Tien
Stephen R Cole
P2860
P304
P356
10.1097/QAI.0B013E318189A780
P407
P577
2008-12-01T00:00:00Z